reference/30468050

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30468050

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	823
issn	1436-3305 1436-3291
issueIdentifier	5
pageRange	811-823
publicationName	Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
startingPage	811
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_df40a2c8358131668b7ee7213b6e84b2 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_13789be5e739d39d0852bb45de4e9c89 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9f4ea851df1f388383d25f790d5c0f68
bibliographicCitation	Lopes N, Bergsland C, Bruun J, Bjørnslett M, Vieira AF, Mesquita P, Pinto R, Gomes R, Cavadas B, Bennett E, Pereira L, Lothe RA, Almeida R, David L. A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis. Gastric Cancer. 2020 Sep;23(5):811–23. doi: 10.1007/s10120-020-01064-6. PMID: 32215766.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76c6a27b1d29617668ee900ca6972eb2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5947991f0f330c9b76e2289faad7a30a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4207-9258 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4732-7361 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b20a78d4ba1f2bbe08bf66897fc751a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af666531e30b1ca29e9344902d1b1d0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5679bb930ce250da193f7db016f65e9c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7274173846d130d26438092784997bcc http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4104-5398 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7021f0df64f491b613bba4cc063af976 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53605a89c65bc55c4431d9a058e3c45a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ccad7de6e0c0b31e9b809413ba17fc4d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1898987387afbf3246671f3fa84fd54 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4766-9831 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b5a2661cd609b3e1426557bde4f82db http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1693-1032 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1cda5e3016f0fd95b90d0a47ba61c8cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a5166a24845b526bd8531c6eb0d7408
date	2020-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s10120-020-01064-6 https://pubmed.ncbi.nlm.nih.gov/32215766
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/26774 https://portal.issn.org/resource/ISSN/1436-3291 https://portal.issn.org/resource/ISSN/1436-3305
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis
discusses	http://id.nlm.nih.gov/mesh/M000615244 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0272383 http://id.nlm.nih.gov/mesh/M0013336 http://id.nlm.nih.gov/mesh/M0024234 http://id.nlm.nih.gov/mesh/M0001409 http://id.nlm.nih.gov/mesh/M0473058 http://id.nlm.nih.gov/mesh/M0471680
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_47e1ad3de5322c7cdeb890f8fcc292a3 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9305 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_66262ff7f492cc412019fb309192d84a

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1045 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID10223 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1015

Total number of triples: 56.